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ABSTRACT
Objective: The objective of this study was to optimize the formulations of antifibrotic tetrandrine beads using alginate and various concentrations of 
hydroxypropyl methylcellulose (HPMC) and chitosan.
Methods: Beads were formulated with six (F1–F6) concentrations of polymer and were then characterized using scanning electron microscopy, 
differential scanning calorimetry, and X-ray diffraction; these beads were used for measurements of moisture contents, swelling, and in vitro drug 
release.
Results: Beads with the highest concentrations of HPMC and chitosan produced the highest entrapment efficiencies of 49.83% and 50.71%, 
respectively. Moreover, drug release under stomach conditions (HCl pH 1.2 medium) was restricted to 75.01%, 61.01%, 51.86%, 74.84%, 66.00%, 
and 41.63% with increasing HPMC and chitosan concentrations (F1–F6, respectively).
Conclusion: Beads of all formulations showed inadequate retention of tetrandrine under pH conditions of the upper gastrointestinal tract and would 
likely be unsuccessful as colon-targeted dosage forms.
Keywords: Alginate, Antifibrotic tetrandrine beads, Chitosan, Hydroxypropyl methylcellulose, Ionic gelation.
INTRODUCTION
Colon-targeted drug delivery was previously used to advance therapy 
for localized disease and to minimize the side effects of drugs in the 
gastrointestinal tract [1]. These systems were designed to reach the 
colon with minimal release of enzyme- and pH-sensitive drugs in 
the upper gastrointestinal tract [2]. Specifically, these drug delivery 
systems should achieve long retention times [3], robustness to unique 
pH conditions [4], decreased doses and side effects, and increase 
bioavailability, especially for drugs with low absorption [5].
pH-sensitive mechanisms are critical to drug delivery systems for 
the gastrointestinal tract because pH conditions vary from highly 
acidic to almost neutral in the colon [4]. Beads are multiparticulate 
systems that have been considered as pharmaceutical dosage forms 
for colon-targeted drug delivery [6] and may be used to control and 
extend drug release [2]. These beads are formed using ionic gelation 
methods to produce cross-linked complexes of polyelectrolyte 
polymers. Tetrandrine is an antifibrotic agent for the treatment of 
intestinal fibrosis, which is characterized by excessive deposition of the 
extracellular matrix under conditions of ulcerative colitis and Crohn’s 
disease [7]. Intestinal fbrosis is caused by an excess deposition of the 
extracellular matrix resulting from chronic inflammation and impaired 
wound healing in the intestine [8]. In addition, patients with fibrosis 
who were not effectively treated with systemic immunosuppressants 
benefited from drugs with localized effects [9], and in another study, 
antifibrotic site-directed effects of tetrandrine were achieved by 
targeting to the colon [10].
Polymers with crosslinking capacity, such as alginate, may facilitate 
tetrandrine delivery to the colon by beads because of the resulting cross-
linked complexes form three-dimensional networks that can be used to 
entrap bioactive substances or drugs [11]. Alginate forms biodegradable 
polymers in which the stability of dosage forms can be manipulated and 
drug release can be controlled according to pH sensitivity, offering the 
potential for colon-targeted drug delivery [12,13]. However, alginate has 
a low drug entrapment efficiency, necessitating the use of combination 
polymers with polymer agents, such as hydroxypropyl methylcellulose 
polymer (HPMC) and chitosan, which improve drug entrapment and 
release profiles [14].
HPMC was chosen due to its stability in the gastrointestinal tract, where 
pH conditions widely vary. HPMC limits drug release at pH 3–11 [15,16]. 
HPMC also establishes semi-interpenetrating networks (semi-IPNs) 
with alginate, leading to the formation of beads when the mixture 
is dropped into calcium chloride solution. Herein, we performed 
experiments with chitosan based on a previous study, showing that 
it can facilitate targeting to the colon [14]. Like HPMC, chitosan is a 
polysaccharide that forms polymers that are biodegradable by colonic 
microflora. Specifically, chitosan formed polyelectrolyte cross-linked 
networks with alginate, and the ensuing electrostatic interactions 
strengthened the bioadhesive characteristics of alginate and facilitated 
drug release [5]. Based on these studies, we formulated tetrandrine-
loaded beads from alginate/HPMC and calcium alginate–chitosan and 
compared colon targeting using six formulations of each with varying 
polymer concentrations.
MATERIALS AND METHODS
Tetrandrine (Shaanxi Ciyuan Biotech, China), tetrandrine standard 
(Sigma Aldrich, Singapore), sodium alginate (Shandong Jiejing 
Group Co., China), calcium chloride (Merck, Germany), HPMC (Wuhan 
Senwayer Century Chemical Co., Ltd., China), chitosan (Bio Chitosan, 
Indonesia), chloride acid (Brataco, Indonesia), potassium phosphate 
monobasic (Merck, Germany), sodium hydroxide (Brataco, Indonesia), 
ethanol (Brataco, Indonesia), Tween 80 (Brataco, Indonesia), and 
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deionized water (Brataco, Indonesia) were purchased from their 
respective suppliers.
Preparation of calcium alginate/HPMC beads
Sodium alginate and HPMC were separately dissolved in demineralized 
water, were mixed and homogenized, and were then slowly cooled to 
room temperature. Tetrandrine was then dissolved in 0.1 N HCl and was 
added to the alginate/HPMC solution and stirred until homogeneous. 
Subsequently, the blended solution was extruded into 2% calcium 
chloride solution using 21G syringe needle with stirring at 200 rpm 
(37°C) for 15 min. Beads were then washed with deionized water and 
dried at room temperature (Table 1).
Preparation of calcium alginate–chitosan beads
Sodium alginate was dissolved in demineralized water and 
tetrandrine was dissolved in 0.1 N HCl, and the two solutions were 
then homogeneously mixed. Calcium chloride was dissolved in 
demineralized water, and chitosan was dissolved separately in 1% 
glacial acetic acid and was mixed with 1 N NaOH to adjust the pH to 
about 4.5. The alginate–tetrandrine solution was then extruded into 2% 
calcium chloride solution using a 26G syringe needle with stirring at 
200 rpm (37°C) for 15 min. The resulting beads were finally washed 
with deionized water and dried at room temperature.
Morphological characterization
Shapes, odors, surface textures, and colors of beads were visually 
determined.
Scanning electron microscopy
Shapes and morphologies of beads were observed using a scanning 
electron microscope (SEM; Hitachi SU-3500, Japan) after placing the 
beads in the sample holder and applying a vacuum [14].
Particle size distributions
The diameters of 300 beads were measured using calipers with 
0.02 mm accuracy, and the mean particle sizes and size distributions 
were calculated [17].
Determination of moisture contents
Moisture contents were measured using a moisture balance (Adam, 
USA). Briefly, bead samples of about 1 g were placed in an aluminum 
pan, and percentage water contents were determined when no further 
weight changes were observed.
Process efficiency
To calculate recovery values, we compared the weights of all materials 
used during the production of beads with the weights of the resulting 
beads using the following formula:
( ) Weight of the dried beads (gram)  × 100%





ncy %  =
Determinations of entrapment efficiencies and drug contents
Entrapment efficiency was measured after extracting tetrandrine from 
beads. To this end, beads were soaked in buffer phosphate-buffered 
saline (PBS) at pH 6.8 for 24 h and were stirred at 100 rpm until they 
disintegrated. HCl (pH 1.2) was then added to a volume of 50 ml, and 
solutions were finally centrifuged at 2500 rpm for 15 min. Supernatants 
were then collected and diluted again to 50 ml in HCl (pH 1.2), and 
tetrandrine contents were determined using a ultraviolet–visible 
(UV-Vis) spectrophotometer (Shimadzu UV-1800, Japan) at 280 nm. 
Entrapment efficiencies and drug contents were calculated using the 
following formulas [18]:





( ) Practical drug loading (mg)  × 100%
Amount of beads (mg
Dr
)
ug content %  =
Differential scanning calorimetry
Tetrandrine, alginate, HPMC, chitosan, calcium chloride, alginate/HPMC 
beads, alginate–chitosan beads, tetrandrine-loaded alginate/HPMC 
beads, and tetrandrine-loaded alginate–chitosan beads were analyzed 
using a differential scanning calorimeter (DSC; Perkin Elmer DSC8000, 
USA). In these analyses, 5 mg samples were placed in aluminum 
cylinders under a flow of nitrogen and were heated at 10°C/min from 
30°C to 350°C.
X-ray diffraction
To determine whether tetrandrine is amorphous or crystalline in 
alginate/HPMC and alginate–chitosan beads, we recorded diffraction 
patterns using an X-ray diffractometer with Cu irradiation at 40 kV 
and 40 mA.
Swelling index analysis
Bead formulations (1 g) were soaked in 25-mL aliquots of PBS (pH 6.8) 
at 37°C and were weighed after 5, 10, 15, 30, 45, and 60 min. Swelling 
indexes were then calculated, as previously described by Pandey 
et al. [19], using the following formula:
( )Percentage swellin 2 1 100
1
g %  −= ×W W
W
Where W1 is the weight of dried beads and W2 is the weight of swollen 
beads.
Fourier-transform infrared (FTIR) analyses
We performed FTIR spectroscopy (Shimadzu FTIR 8400S, Japan) 
to investigate interactions between the components in prepared 
formulations [20]. Samples of alginate, HPMC, chitosan, their composite 
beads, and loaded beads were crushed with dry potassium bromide, 
and analyses were performed at 400–4000 cm−1.
In vitro drug release studies
Beads were placed in 0.1 N HCl for 2 h, followed by PBS (pH 7.4) for 3 h, 
and then PBS (pH 6.8) for 2 h. PBS solutions contained Tween 80 (2%, 
v/v) [2]. 10-ml aliquots of dissolution fluid were withdrawn at regular 
intervals and were immediately replaced with the same volume of fresh 
media. Samples were then analyzed using a UV-Vis spectrophotometer 
at wavelength maxima for each analyte. Sample contents at n min were 
calculated using the following formula:
Table 1: Composition of the calcium alginate/HPMC and calcium alginate–chitosan beads containing tetrandrine
Formula Alginate (%, w/v) Calcium chloride (%, w/v) HPMC (%, w/v) Chitosan (%, w/v) Tetrandrine (%, w/v)
Control 2 2 - - 1
F1 2 2 0.5 - 1
F2 2 2 1 - 1
F3 2 2 2 - 1
F4 2 2 - 0.25 1.25
F5 2 2 - 0.5 1.25
F6 2 2 - 0.75 1.25
HPMC: Hydroxypropyl methylcellulose
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yn a  x fp x M yn a  x fp x S
n minute mg
b x b x 
Where yn is tetrandrine absorption at n min, x is the tetrandrine 
concentration, fp is a dissolution factor, M is the volume of release 




Beads sizes were determined for 300 beads from each formula using 
calipers with 0.02 mm accuracy. From subsequent calculations of mean 
sizes, 39% of control beads were distributed between 589 and 671 µm, 
whereas 19% of F1 beads were 772–809 µm. F2 bead sizes were 
distributed in 16% portions at 802–835 µm and 836–869 µm, 15% of 
F3 beads were 888–914 µm, 30% of F4 beads were 1058–1100 µm, and 
20.67% of F6 beads were 1088–1125 µm. These particle size distributions 
(Table 2) showed that increasing polymer concentrations are associated 
with increased bead sizes. Higher concentrations of chitosan and HPMC 
polymers also contributed to higher retention of mixtures during the 
gelation process, likely explaining the production of larger beads.
Moisture content determination
In evaluations of process efficiency (Table 2), water contents of beads 
indicated hygroscopic properties, similar to those of calcium chloride. 
In agreement, HPMC is an ether cellulose that acts as a hydrophilic 
carrier [21].
Process efficiency
Process efficiencies of F1, F2, F3, F4, F5, and F6 and control beads were 
28.85%, 26.62%, 19.92%, 18.98%, 46.95%, and 42.5% and 51.85%, 
respectively.
Entrapment efficiency and drug content determinations
The present formulas varied in their capacities to entrap drug substances 
(Table 2). In experiments with control beads, complexes were not 
strong enough and had porous surfaces that allowed drug diffusion 
during the gelation process. We also found that entrapment efficiency 
increased with polymer concentrations. Foremost, interactions between 
alginate carboxyl groups and amine protons of chitosan limited the drug 
diffusion into the medium during gelation, indicating increased solidity 
of the polymer layers in beads containing alginate or chitosan [22].
Morphological characterization
Wet alginate/HPMC beads were spherical and were whitish, whereas 
alginate–chitosan wet beads were spherical and yellowish. None of 
the beads had strong odors, although alginate–chitosan beads had a 
weak acidic odor. On drying, beads turned into a yellowish color due to 
changes in density (Fig. 1).
SEM analyses
All formulations were observed to be vaguely spherical at 100× 
magnification, and rough, wavy, porous, and creviced surfaces were 
visible at 500× magnification (Fig. 2).
DSC analyses
In thermograms, melting points of the present bead-forming materials 
differed from those of the formed beads, reflecting chemical interactions 
between components. In particular, exothermic peaks disappeared 
in unloaded beads, suggesting that alginate forms a more solid bead 
structure [23], indicating the establishment of interactions between 
alginate and HPMC in the formed beads.
Unloaded alginate–chitosan beads showed two endothermic peaks 
at 75.22°C and 205.46°C, with corresponding melting energies 
of 142.38 J/g and 20.12 J/g and an exothermic peak at 274.86°C 
(117.462 J/g). Loaded alginate–chitosan beads had an endothermic 
peak at 75.71°C (181.52 J/g) and an exothermic peak at 272.91°C 
(41.21 J/g).
X-ray diffraction
The present diffractograms showed that tetrandrine is in the crystalline 
phase (Fig. 3), but only small, short, and tight peaks were identified 
for alginate/HPMC beads. In contrast, alginate–chitosan beads 
decreased peak heights compared with those of tetrandrine. Some 
peaks also indicated decreases in drug crystallinity. These data further 
indicated that tetrandrine was dispersed inside these beads [24] and 
is compatible with their polymeric matrixes [25]. Peak disappearances 
in diffractograms indicated the formation of amorphous materials, 
and differences in peaks reflect the sizes of vestigial tetrandrine 
crystals [26].
Swelling index
F1, F2, F3, F4, F5, and F6 formulas swelled by 561.08%, 1021.36%, 
1116.53%, 937.68%, 646.3%, and 622.33%, respectively, over 1 h.
FTIR spectroscopy analysis
FTIR spectra of alginate showed an asymmetric carboxyl group at 
1608 cm−1 and a symmetrical carboxyl group at 1429 cm−1. G and M 
uronic acid were also detected at 1030 cm−1 and 1050 cm−1, respectively. 











Control 704.27 10.44±1.02 28.85 22.73±1.42 8.74±0.55
F1 758.70 9.06±0.52 26.62 29.60±1.61 8.46±0.46
F2 852.61 9.46±0.22 19.92 37.58±0.11 9.39±0.03
F3 903.52 9.67±0.06 18.98 49.83±0.46 9.97±0.09
F4 920.27 11.69±0.78 46.95 42.26±1.62 14.09±0.54
F5 994.8 10.76±1.15 42.5 42.93±1.29 15.33±0.46
F6 1054.6 9.06±0.69 51.85 50.71±0.31 16.90±0.10
SD: Standard deviation
Fig. 1: Beads changed color into a yellowish
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HPMC in beads had spectra in the range 3500–3400 cm−1, with stretching 
vibrations of methyl and propyl groups at 2900 cm−1, cyclic groups at 
1650–1600 cm−1, broad peaks for cyclic anhydride at 1400–1350 cm−1, 
and a pyranose ring at 1000–950 cm−1 [12]. Tetrandrine spectra showed 
the presence of C–N groups at 1125 cm−1, the main spectra of benzene at 
1455 and 1637 cm−1, and ether spectra at 1025 and 1315 cm−1.
Chitosan showed N-–H groups at 1655 cm−1, C–N groups at 1315 cm−1, 
and ether groups at 1151 and 1180 cm−1 (Fig. 4) [14,27].
In vitro release study
In this study, drug release from beads was shown to be high under acidic 
conditions (HCl at pH 1.2), which represent the stomach environment, 
with the release of >50% of tetrandrine after 120 min. These observations 
are consistent with the known acid solubility of tetrandrine [28], but this 
release may also be affected by the porous and rough surfaces of beads. 
Hence, under these conditions, semi-IPNs of alginate and HPMC were not 
strong enough to protect the drugs. Colon-targeted drugs require protection 
until arrival at the colon, which we modeled using PBS at pH 6.8 (Fig. 5) [29].
Fig. 2: Scanning electron micrograph under 100x and 500x magnification
Fig. 3: Diffractograms of (a) tetrandrine (b) tetrandrine loaded alginate/HPMC beads, and (c) tetrandrine loaded alginate-chitosan beads
a b
c
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DISCUSSION
Alginate beads with lower HPMC concentrations produced wavier 
surfaces than those with higher concentrations. Rough and porous 
surfaces were also related to the viscosity of polymer matrix, with lower 
viscosities decreasing the density of dried beads and causing more wavy 
surfaces and smaller sizes and shapes [30]. Alginate–chitosan beads 
had more varying shapes than control beads, reflecting interactions 
between alginate and chitosan and production of more solid structures. 
Surface wrinkles were also fewer than on control beads, and a solid 
structure followed the formation of electrostatic interactions between 
alginate and chitosan. pH adjustments may also influence interactions 
between carboxylate groups in alginate and chitosan [14].
The viscosity of alginate/HPMC mixtures affected the diameters and 
densities of beads and the volumes of entrapped drug substance. 
Fig. 4: FTIR spectra
Fig. 5: Cumulative drug release
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Alginate–chitosan beads increased in diameter with increasing 
chitosan concentrations, reflecting the formation of polyelectrolyte 
complexes between carboxyl groups of alginate and amine groups 
of chitosan [31-34]. Previous studies have shown that bead sizes are 
normally distributed over 50–2000 µm [35]. The alginate–chitosan 
beads in the present study had greater average diameters and entrapped 
more water than alginate/HPMC beads, as indicated by higher moisture 
contents; however, this led to suboptimal process efficiency due to 
shrinking during drying phases and manual processing.
Swelling indexes of alginate/HPMC beads increased with increasing 
concentrations of HPMC, and this likely relates to its hydrophilic 
properties. In contrast, swelling indexes of alginate–chitosan beads 
decreased with increasing chitosan concentrations, leading to a 
stronger structure with increased stability under basic conditions. 
These structures also became more rigid with increasing chitosan 
concentrations and with the formation of inter- and intra-polymer 
linkages on beads [14]. Swelling of beads is caused by differences in 
osmotic pressure between beads and their surrounding media, as 
shown in the determination of swelling indexes, in which penetration 
of solution caused polymer relaxation and swelling of beads [12,25].
Reactions between alginate and chitosan were confirmed by the 
disappearance of exothermic alginate peaks at 249.08°C, and exothermic 
chitosan peaks at 306.96°C were replaced with new exothermic peaks 
at 274.86°C. Furthermore, an acquired endothermic peak at 205.46°C 
indicated the formation of a linkage between carboxylic ion on 
alginate and an amine on chitosan. The disappearance of tetrandrine 
peaks indicated that tetrandrine molecules were dispersed on the 
beads [27,36]. These observations also showed that tetrandrine is 
entrapped on beads and is chemically altered by heat.
Spectral displacements of alginate carboxylic groups were observed 
after the formation of complexes with chitosan, with peak shifts from 
1608 and 1429 cm−1 to 1616 and 1447 cm−1, respectively (Fig. 5). A new 
peak was also observed at 2886 cm−1, indicating a CH2 vibration of 
chitosan [14]. A crosslinking interaction between alginate and calcium 
ions was evident from a shift of the carboxylic group wavenumber from 
1622 to 1634 cm−1 (Fig. 4). No interactions between the drug substance 
and polymers were evident in these studies, with no significant spectral 
differences between unloaded and loaded beads.
In a previous study, beads with pores and crevices were associated 
with diffusion of drugs during gelation [14]. Alginate/HPMC and 
alginate–chitosan beads were porous and had crevices, although drug 
release from alginate–chitosan beads was lower than from alginate/
HPMC beads, likely reflecting the density of alginate–chitosan beads 
and inter- and intra-polymer interactions of alginate, chitosan, and 
calcium chloride. Swelling indexes were also related to the release of 
drugs, and beads with lower swelling indexes restrained drugs from the 
premature release [14].
CONCLUSION
Beads from the present formulations prematurely released tetrandrine 
in HCl at pH 1.2. Therefore, calcium alginate–chitosan and alginate/
HPMC beads containing tetrandrine may fail as colon-targeted dosage 
forms.
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